Journal articles: 'Tobacco Use Disorder'

1

Leone, Frank T., and Sarah Evers-Casey. "Tobacco Use Disorder." Medical Clinics of North America 106, no. 1 (January 2022): 99–112. http://dx.doi.org/10.1016/j.mcna.2021.08.011.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

DiFranza, Joseph R., Chaya Bhuvaneswar, Denise Jolicoeur, Susanne E. Tanski, and Jonathan Winickoff. "Tobacco Use Disorder." Journal of Addiction Medicine 10, no. 3 (2016): 143–47. http://dx.doi.org/10.1097/adm.0000000000000181.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Schmidt, Lasse David, Elisa Wegmann, Anja Bischof, Lena Klein, Chang Zhou, Dmitri Rozgonjuk, Christopher Kannen, et al. "Implicit Cognitions, Use Expectancies and Gratification in Social-Networks-Use Disorder and Tobacco Use Disorder." SUCHT 68, no. 5 (October 1, 2022): 279–91. http://dx.doi.org/10.1024/0939-5911/a000782.

Full text

Abstract:

Abstract: Aims: The problematic use of social networks is discussed as a further specific type of Internet-use disorders. Our project aims to clarify whether social-networks-use disorder (SNUD) is marked by characteristics of addictive behaviors by tracking behavior and investigating the relevance of 1) implicit cognitions, 2) the experiences of gratification and compensation and 3) use expectancies in SNUD compared to tobacco-use disorder. Methodology: Four groups will be examined: individuals with 1) SNUD without tobacco use, 2) risky use patterns with regard to social networks without tobacco use, 3) tobacco use disorder and 4) healthy controls. All participants first complete a laboratory examination including the Implicit Association Test (IAT) and the Approach-Avoidance task (AAT). We will use smartphone-based data tracking for 14 days following laboratory testing to record smoking and social-networks-use patterns. During this period, we further measure use expectancies and the experience of gratification and compensation by means of a smartphone-based experience sampling method (ESM). Conclusions: This is the first study to examine relevant characteristics of addictive behaviors in individuals with SNUD compared to individuals with tobacco use, using a combination of experimental psychological methods and smartphone-based measurements. We expect that this investigative approach will contribute to a deeper understanding of the processes involved in SNUD.

APA, Harvard, Vancouver, ISO, and other styles

4

Zawertailo, Laurie, Sophia Attwells, Wayne K. deRuiter, Thao Lan Le, Danielle Dawson, and Peter Selby. "Food Addiction and Tobacco Use Disorder: Common Liability and Shared Mechanisms." Nutrients 12, no. 12 (December 15, 2020): 3834. http://dx.doi.org/10.3390/nu12123834.

Full text

Abstract:

As food addiction is being more commonly recognized within the scientific community, parallels can be drawn between it and other addictive substance use disorders, including tobacco use disorder. Given that both unhealthy diets and smoking are leading risk factors for disability and death, a greater understanding of how food addiction and tobacco use disorder overlap with one another is necessary. This narrative review aimed to highlight literature that investigated prevalence, biology, psychology, and treatment options of food addiction and tobacco use disorder. Published studies up to August 2020 and written in English were included. Using a biopsychosocial lens, each disorder was assessed together and separately, as there is emerging evidence that the two disorders can develop concurrently or sequentially within individuals. Commonalities include but are not limited to the dopaminergic neurocircuitry, gut microbiota, childhood adversity, and attachment insecurity. In addition, the authors conducted a feasibility study with the purpose of examining the association between food addiction symptoms and tobacco use disorder among individuals seeking tobacco use disorder treatment. To inform future treatment approaches, more research is necessary to identify and understand the overlap between the two disorders.

APA, Harvard, Vancouver, ISO, and other styles

5

Thomson, Daniel, Michael Berk, Seetal Dodd, Marta Rapado-Castro, Shae E. Quirk, Pernille K. Ellegaard, Lesley Berk, and Olivia M. Dean. "Tobacco Use in Bipolar Disorder." Clinical Psychopharmacology and Neuroscience 13, no. 1 (April 30, 2015): 1–11. http://dx.doi.org/10.9758/cpn.2015.13.1.1.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Sinha, Shirshendu, and Ajay Shah. "Pharmacotherapy of Tobacco Use Disorder." American Journal of Psychiatry Residents' Journal 11, no. 9 (September 2016): 8–12. http://dx.doi.org/10.1176/appi.ajp-rj.2016.110903.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Davis, Ashley. "Pharmacotherapy for Treatment of Tobacco Use Disorder." Journal of Psychosocial Nursing and Mental Health Services 61, no. 11 (November 2023): 6–9. http://dx.doi.org/10.3928/02793695-20231011-02.

Full text

Abstract:

Tobacco use disorder (TUD), the leading cause of preventable deaths in the United States, disproportionally impacts those with psychiatric disorders. There are multiple first-line, U.S. Food and Drug Administration–approved pharmacotherapy options for the treatment of TUD. The current review focuses on these medications, underlining practical tips to improve cessation rates, while emphasizing a harm reduction and patient-centered approach to treatment. [ Journal of Psychosocial Nursing and Mental Health Services, 61 (11), 6–9.]

APA, Harvard, Vancouver, ISO, and other styles

8

Benowitz, Neal L., and Evangelia Liakoni. "Tobacco use disorder and cardiovascular health." Addiction 117, no. 4 (October 20, 2021): 1128–38. http://dx.doi.org/10.1111/add.15703.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Fernandes, Thiago P., Steven M. Silverstein, Natalia L. Almeida, and Natanael A. Santos. "Visual impairments in tobacco use disorder." Psychiatry Research 271 (January 2019): 60–67. http://dx.doi.org/10.1016/j.psychres.2018.11.024.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Chawla, Megha, and Kathleen A. Garrison. "Neurobiological Considerations for Tobacco Use Disorder." Current Behavioral Neuroscience Reports 5, no. 4 (October 30, 2018): 238–48. http://dx.doi.org/10.1007/s40473-018-0168-3.

Full text

APA, Harvard, Vancouver, ISO, and other styles

11

Verplaetse, Terril L., Kelly E. Moore, Brian P. Pittman, Walter Roberts, Lindsay M. Oberleitner, Philip H. Smith, Kelly P. Cosgrove, and Sherry A. McKee. "Intersection of Stress and Gender in Association With Transitions in Past Year DSM-5 Substance Use Disorder Diagnoses in the United States." Chronic Stress 2 (January 2018): 247054701775263. http://dx.doi.org/10.1177/2470547017752637.

Full text

Abstract:

Background Stress contributes to the development and maintenance of substance use disorders, with some research suggesting that the impact of stress on substance use disorders is greater in women. However, this has yet to be evaluated in a national dataset, across major substances of abuse. Methods Using data from the newly available U.S. National Epidemiologic Survey on Alcohol and Related Conditions (NESARC; Wave 3; n = 36,309), we evaluated relationships among past year stressful life events (0 or 1 vs. 2+ events, range 0–16) and gender, and their association with transitions (new vs. absent cases; ongoing vs. remitted cases) in Diagnostic and Statistical Manual of Mental Disorders Fifth Edition alcohol use disorder, tobacco use disorder, cannabis use disorder, and nonmedical prescription opioid use disorder diagnoses. Results Having two or more stressful life events in the past year increased the odds of having a new alcohol use disorder, tobacco use disorder, cannabis use disorder, and opioid use disorder (OR = 3.14, 2.15, 5.52, and 3.06, respectively) or ongoing alcohol use disorder, tobacco use disorder, and cannabis use disorder (OR = 2.39, 2.62, and 2.95, respectively) compared to zero or one stressful life event. A stress by gender interaction for new vs. absent alcohol use disorder demonstrated that having two or more stressful life events was associated with increased odds of new alcohol use disorder in men (OR = 2.51) and even greater odds of new alcohol use disorder in women (OR = 3.94). Conclusions Results highlight that stress is a robust factor in both men and women with new or ongoing substance use disorders, and that effective treatments for substance use should consider the role of stress in addiction etiology and maintenance. There was little evidence for gender differences in the role of stress on transitions in substance use disorders, except for the onset of alcohol use disorders. Given that rates of alcohol use disorders are increasing in women, the impact of stress needs to be considered.

APA, Harvard, Vancouver, ISO, and other styles

12

Trull, Timothy J., Carol J. Waudby, and Kenneth J. Sher. "Alcohol, Tobacco, and Drug Use Disorders and Personality Disorder Symptoms." Experimental and Clinical Psychopharmacology 12, no. 1 (2004): 65–75. http://dx.doi.org/10.1037/1064-1297.12.1.65.

Full text

APA, Harvard, Vancouver, ISO, and other styles

13

Witt, Daniel R., and Christi A. Patten. "Treatment of Tobacco Use Disorder and Mood Disorders in Adolescents." Current Addiction Reports 5, no. 3 (June 11, 2018): 346–58. http://dx.doi.org/10.1007/s40429-018-0216-9.

Full text

APA, Harvard, Vancouver, ISO, and other styles

14

Bucklin, Matthew. "A 5-Factor Framework for Assessing Tobacco Use Disorder." Tobacco Use Insights 14 (January 2021): 1179173X2199835. http://dx.doi.org/10.1177/1179173x21998355.

Full text

Abstract:

Cigarette use is the leading cause of preventable death in the United States. Despite the well documented dangers of smoking, nearly 20% of adults report regular use of tobacco. A majority desire to discontinue but the long-term cessation success rate remains near 4%. One challenge to reducing the prevalence of tobacco use is an incomplete understanding of the individual correlates that reinforce continued use. Evidence from research on nicotine and tobacco suggests that Tobacco Use Disorder is a complex, and multifactorial condition. Personality traits, comorbidities, habits and lifestyle, genetics, socioeconomic status, and mental and physical health all contribute to the risk for dependence and to the likelihood of quitting. This perspective review provides an overview of some common factors that contribute to liability risk for Tobacco Use Disorder and a framework for assessing individual tobacco users. The framework includes 5 areas that research suggests contribute to continued tobacco use: nicotine addiction, psychological influences, behavioral dependencies, neurobiological factors, and social reinforcement. Nicotine addiction includes drug-seeking behavior and the role of withdrawal avoidance. Psychological and emotional states contribute to a perceived reliance on tobacco. Behavioral dependence is reinforced by associative and non-associative learning mechanisms. Neurobiological factors include genetic variables, variations in neurotransmitters and receptors, pharmacogenetics, and interaction between psychiatric illnesses and nicotine use and dependence. Finally, social reinforcement of smoking behavior is explained by a network phenomenon and consistent visual cues to smoke. A comprehensive assessment of individual tobacco users will help better determine appropriate treatment options to achieve improved efficacy and outcomes.

APA, Harvard, Vancouver, ISO, and other styles

15

Okoli, Chizimuzo T. C., and Sarret Seng. "Correlates of Tobacco Use and Consumption Among Hospitalized Psychiatric Patients." Western Journal of Nursing Research 41, no. 8 (January 18, 2019): 1121–36. http://dx.doi.org/10.1177/0193945918823483.

Full text

Abstract:

Using a cross-sectional analysis, we assessed correlates of tobacco use and tobacco consumption from inpatient records ( N = 2,060) from a state psychiatric hospital. We used multivariate logistic regression analyses to examine correlates of tobacco use in the total sample and multivariate linear regression to examine correlates of tobacco consumption among tobacco users. Tobacco-use associated variables in the total sample were being male, being White, lower education, having a substance-use disorder/treatment, having an externalizing or psychotic disorder, being from a rural county, being younger, and shorter length of hospital stay. Among tobacco users ( n = 1,153), correlates of amount of tobacco consumption were being male; being White; lower education; having an internalizing, externalizing, and psychotic disorder; using cigarettes; and living in a county without a smoke-free policy. Psychiatric patients should be screened for specific associative variables as part of tobacco-use assessments. Future research may expand on the current findings to develop strategies to enhance tobacco treatment among psychiatric patients.

APA, Harvard, Vancouver, ISO, and other styles

16

Limbu, Suren, D. R. Shakya, N. Sapkota, and R. Gautam Joshi. "Tobacco Use and Dependence among Psychiatry Out-Patients of a Health Institute in Eastern Nepal." Journal of BP Koirala Institute of Health Sciences 2, no. 1 (July 24, 2019): 68–76. http://dx.doi.org/10.3126/jbpkihs.v2i1.24972.

Full text

Abstract:

Background: Assessment of nicotine dependence among tobacco users is essential as highly dependent individuals have greater risk of developing tobacco related physical and psychiatric problems. There is little information about the tobacco use and nicotine dependence among psychiatric patients in developing countries, including Nepal. Objectives: To estimate the prevalence of tobacco use, the level of nicotine dependence and the psychiatric disorder specific prevalence among tobacco users visiting a psychiatry out-patient department. Materials and methods: A cross-sectional study was conducted in Out-patient setting of Department of Psychiatry, B. P. Koirala Institute of Health Sciences (BPKIHS). Ninety cases (calculated sample size) were enrolled. The Fagerström Test for Nicotine Dependence (FTND) was applied to assess the level of nicotine dependence and the Mini International Neuropsychiatric Interview (MINI) for diagnosis of Psychiatric disorders. Results: The prevalence of tobacco use was 55.6%. Tobacco use was more common among males (pvalue < 0.05). Smokeless form was the common form of tobacco. Majority of them had started their consumption in their adolescence. Most users had moderate nicotine dependence. Major depressive disorder and Alcohol dependence were the most common diagnoses among tobacco users. Conclusion: More than half of the psychiatry out-patients consumed tobacco. Future studies that help to understand the relationship and possible mechanism of increased tobacco use in patients with psychiatry disorders are required. Tobacco control and prevention strategies should be initiated targeting vulnerable populations such as male gender and adolescent.

APA, Harvard, Vancouver, ISO, and other styles

17

Wang, Zihan. "Nicotine Addiction, Alcohol Use Disorder and Bipolar Disorder." Highlights in Science, Engineering and Technology 74 (December 29, 2023): 116–20. http://dx.doi.org/10.54097/wxst4p21.

Full text

Abstract:

Bipolar affective disorder has a wide range of effects on human health and is extremely harmful, and the mortality rate of patients continues to grow. Meanwhile, most people, especially those with mental illness, tend to numb themselves by smoking and drinking. Unfortunately, tobacco and alcohol abuse are also extremely harmful to human health, moreover, the cost of living will be increased due to addiction of these things. At the same time, the unconscious mind after using alcohol and tobacco has also brought great uneasiness to society, thus leading to increased burden on individuals and society. This review discusses the genetics, comorbidity, and treatment of nicotine dependence, alcohol use disorder, and bipolar disorder, and finds that the severity of bipolar disorder patients is positively correlated with the severity of alcohol use disorder and nicotine dependence. Both patients with bipolar disorder and alcohol use disorder exhibit mutations in the BDNF gene, and an age peak in bipolar disorder coincides with a peak in nicotine dependence. In the end, it is believed that the interaction between comorbidities may become a breakthrough in the diagnosis or treatment of bipolar disorder in the future, and the easy-to-observe alcohol and nicotine intake can be used to assist in judging the current state of patients.

APA, Harvard, Vancouver, ISO, and other styles

18

Cotaina, Miriam, Marc Peraire, Mireia Boscá, Iván Echeverria, Ana Benito, and Gonzalo Haro. "Substance Use in the Transgender Population: A Meta-Analysis." Brain Sciences 12, no. 3 (March 10, 2022): 366. http://dx.doi.org/10.3390/brainsci12030366.

Full text

Abstract:

(1) Background: This meta-analysis aimed to assess the relationship between identifying as transgender and substance use. (2) Methods: We searched for relevant studies in PubMed, Scopus, the Web of Science, and PsycINFO on 21 July 2021. (3) Results: Twenty studies comparing transgender and cisgender people were included in this work, accounting for a total of 2,376,951 participants (18,329 of whom were transgender). These articles included data on current tobacco use, current tobacco use disorder, current alcohol use, current alcohol use disorder, lifetime substance (all) use, current substance use (excluding tobacco and alcohol), current use of specific substances (excluding tobacco and alcohol and including cocaine, amphetamines, methamphetamines, ecstasy, stimulants, heroin, opiates, cannabis, marijuana, LSD, hallucinogens, steroids, inhalants, sedatives, Ritalin or Adderall, diet pills, cold medicine, prescription medications, polysubstance, other club drugs, and other illegal drugs), and current substance use disorder (excluding tobacco and alcohol). We used the ORs and their 95% CIs to state the association between identifying as transgender and those variables. The control reference category used in all cases was cisgender. We employed a random-effects model. Transgender people were more likely to use tobacco (odds ratio (OR) = 1.65; 95% CI [1.37, 1.98]), have used substances throughout their lives (OR = 1.48; 95% CI [1.30, 1.68]), and present current use of specific substances (OR = 1.79; 95% CI [1.54, 2.07]). When current alcohol and substance use in general and tobacco, alcohol, and substance use disorders specifically were considered, the likelihood did not differ from that of cisgender people. (4) Conclusions: The presence of substance use disorders did not differ between transgender and cisgender people. Considering this population as consumers or as addicted may be a prejudice that perpetuates stigma. Nonetheless, transgender people were more likely to use tobacco and other substances, but not alcohol. Hypothetically, this might be an emotional regulation strategy, a maladaptive mechanism for coping with traumatic experiences, or could respond to minority stress, produced by stigma, prejudice, discrimination, and harassment. It is of particular importance to implement policies against discrimination and stigmatisation and to adapt prevention and treatment services so that they are inclusive of the 2SLGBTQIA+ community.

APA, Harvard, Vancouver, ISO, and other styles

19

Kager, Emily, Joseph Kim, Peter Spyrou, and Lisa B. Dixon. "The Imperative to Treat Tobacco Use Disorder." Psychiatric Services 75, no. 7 (July 1, 2024): 722. http://dx.doi.org/10.1176/appi.ps.24075011.

Full text

APA, Harvard, Vancouver, ISO, and other styles

20

Afridi, I. "Pattern of Tobacco Use among Children and Adolescents with comorbid Psychiatric Illnesses." European Psychiatry 65, S1 (June 2022): S831. http://dx.doi.org/10.1192/j.eurpsy.2022.2152.

Full text

Abstract:

Introduction Tobacco use is clearly harmful for mental as well as physical health especially among persons <18 yeards age. It is used in multiple forms in many countries such as, somoling chewing etc. It is impotant to know the pattern of tobacco use and the comorbid psychiatric illnesses inthis age group. Objectives To identify the pattern of tobacco use among cases <18 years age with various psychiatric disorders. Methods It was a cross-sectional study conducted at a psychiatric clinic at Karachi, on all consecutive cases <18 years. Diagnostic criteria of ICD-10 were used. Results A total number of 700 consecutive cases below the age of 18 years reporting to psychiatric clinic were inducted in this study. Out of them 107 (15%) patients reported use of tobacco. Among them 83 (77% ) used pan with tobacco. The psychiatric illnesses identified were depressive disorder (39%) & conversion disorder (15%). Conclusions Tobacco use (predominantly in the form of chewing), is common amongst children and adolescents reporting for psychiatric consultation. It is important to develop strategies at a community level with legal restriction/implementation selling tobacco to children. Moreover, psychiatric evaluation should be done in all children and adolescents identified as using tobacco, and the term “smoking cessation clinic” should be replaced with “tobacco cessation clinic/ services”. Disclosure No significant relationships.

APA, Harvard, Vancouver, ISO, and other styles

21

George, Aishwariya Brigit, Abhishek Gupta, Raka Jain, Mamta Sood, and Siddharth Sarkar. "Serum brain-derived neurotrophic factor level and its relation with cannabis use disorder and schizophrenia: A cross-sectional exploratory study in patients at a tertiary care hospital." Indian Journal of Pharmacology 56, no. 2 (March 2024): 91–96. http://dx.doi.org/10.4103/ijp.ijp_771_22.

Full text

Abstract:

Abstract BACKGROUND: Brain-derived neurotrophic factor (BDNF) has considerable relevance in neural growth and differentiation. It has been evaluated as a biomarker for individuals with various psychiatric disorders such as substance-related disorders and psychotic disorders. OBJECTIVE: The present study explored differences in the levels of BDNF (in serum) among subjects using cannabis (with and without schizophrenia). METHODS: This cross-sectional observational study compared the serum BDNF level in male subjects aged 18–45 years. Four groups of 20 subjects each were included: individuals with tobacco use disorder only, patients having schizophrenia, patients with cannabis use disorder, and finally patients with comorbid cannabis use disorder and schizophrenia. RESULTS: The BDNF levels were found to be significantly different across the four groups. The BDNF levels in subjects with concurrent schizophrenia and cannabis use disorder were higher than each of the other three groups (cannabis use disorder, schizophrenia, and tobacco use disorder only). CONCLUSION: We find that BDNF may be higher when cannabis use disorder and schizophrenia co-occur, as compared to either of the conditions alone. The findings should be interpreted with caution due to the low sample size and potential confounders.

APA, Harvard, Vancouver, ISO, and other styles

22

Michael, H. Boyle, and R. Offord David. "Psychiatric Disorder and Substance Use in Adolescence." Canadian Journal of Psychiatry 36, no. 10 (December 1991): 699–705. http://dx.doi.org/10.1177/070674379103601001.

Full text

Abstract:

This article examines the relationship between psychiatric disorder and the use of tobacco, alcohol, marijuana and hard drugs during adolescence. The sample of 1,302 adolescents aged 12 to 16 came from households selected by stratified, cluster and random sampling of the 1981 Canada Census. Symptom checklists were used to approximate diagnoses of conduct disorder, attention deficit disorder and emotional disorder. Logistic regression analyses indicated that conduct disorder was strongly related to all types of substance use and that emotional disorder was related to the use of tobacco, alcohol and hard drugs. These relationships were true for the adolescents' self-assessments only; the parents' assessments of psychiatric disorder were not related to the adolescents' reports of substance use.

APA, Harvard, Vancouver, ISO, and other styles

23

Kang, Sam, Denise Razzouk, Jair Jesus de Mari, and Itiro Shirakawa. "The mental health of Korean immigrants in São Paulo, Brazil." Cadernos de Saúde Pública 25, no. 4 (April 2009): 819–26. http://dx.doi.org/10.1590/s0102-311x2009000400013.

Full text

Abstract:

This study investigated the frequency of lifetime mental disorders among Korean immigrants in the city of São Paulo, Brazil. Snowball sampling with multiple focuses was used to recruit Korean immigrants older than 18 years and living in São Paulo. A total of 324 Korean immigrants were selected and their mental status was evaluated using a structured interview, namely the Portuguese or the Korean version of the Composite International Diagnostic Interview 2.1. The diagnoses of mental disorders were made according to the ICD-10. The frequency of any lifetime psychiatric disorder was 41.9%. The frequencies of main disorders were: anxiety disorder, 13% (post-traumatic stress disorder, 9.6%); mood disorder, 8.6%; somatoform disorders, 7.4%; dissociative disorder, 4.9%; psychotic disorder, 4.3%; eating disorder, 0.6%; any substance (tobacco, alcohol, drugs) use disorder, 23.1%. The frequency of any psychiatric disorder except alcohol and tobacco use disorders was 26.2%. Korean immigrants have more psychiatric disorders than the Korean population in Korea, particularly post-traumatic stress disorder, and almost the same rate as the Brazilian population. Mental health authorities should promote a healthier integration and the development of culturally sensitive mental health programs for Korean immigrants.

APA, Harvard, Vancouver, ISO, and other styles

24

Limbu, Suren, Dhana Ratna Shakya, Nidesh Sapkota, and Rinku Gautam. "Tobacco Use, Dependence and Psychiatric Comorbidity in the Community of Dharan." Journal of Psychiatrists' Association of Nepal 11, no. 1 (June 30, 2022): 24–28. http://dx.doi.org/10.3126/jpan.v11i1.53849.

Full text

Abstract:

Introduction: Though there are studies in the past done to assess the prevalence of tobacco use in the country, little is known about the state of nicotine dependence among tobacco users and the co-occurrence of nicotine dependence and psychiatric disorders in Nepal. Objectives: To estimate the prevalence of tobacco use, the level of nicotine dependence among the users and the psychiatric disorder-specific prevalence among tobacco users in a community settng. Methodology A cross-sectional study was conducted in the community of Dharan. One hundred twenty-eight cases (size) were enrolled from different wards of Dharan using the Population proportionate random sampling technique. The Fagerström Test for Nicotine Dependence (FTND) was applied to assess the level of nicotine dependence and the Mini International Neuropsychiatric Interview (M.I.N.I.) was for the diagnosis of Psychiatric disorders. Result: The prevalence of tobacco use was 41.4%. Tobacco use was more common among males and those with a family history of tobacco use and psychiatric illness (p-value< 0.05). The smoking form was more common than smokeless one. Most tobacco users had moderate nicotine dependence and started the use in their 20s. Among tobacco users, 23 cases had comorbid psychiatric diagnoses, common being alcohol and other substance, depression and anxiety disorders. Conclusion: The prevalence of tobacco use was high in the community. Young persons in their 20s should be given special attention while conducting educational and awareness programs regarding tobacco prevention. Psychiatric comorbidities should be assessed routinely among tobacco users.

APA, Harvard, Vancouver, ISO, and other styles

25

Masroor, Anum, Rikinkumar S. Patel, Narmada N. Bhimanadham, Sanjeetha Raveendran, Naveed Ahmad, Uwandu Queeneth, Amaya Pankaj, and Zeeshan Mansuri. "Conduct Disorder-Related Hospitalization and Substance Use Disorders in American Teens." Behavioral Sciences 9, no. 7 (July 5, 2019): 73. http://dx.doi.org/10.3390/bs9070073.

Full text

Abstract:

Objective: Our study aimed to compare the demographic characteristics of conduct disorder (CD) inpatients versus other psychiatric inpatients in children and adolescents, and assess the association between conduct disorder patients and the spectrum of substance use disorders (SUD). Methods: We included 800,614 psychiatric adolescent (12–18 years) inpatients, and this included 8885 inpatients (1.1%) primarily for conduct disorder in the Nationwide Inpatient Sample (2010–2014). ICD-9 codes were used to detect SUD, and a logistic regression model was used to evaluate the odds ratio (OR) for SUD in conduct disorder inpatients. Results: A higher proportion of conduct disorder inpatients were of 12–15 years of age (62.6%), male (64.4%), and White (45.7%). The lower median household income was correlated with a higher prevalence of conduct disorder (36.4%). Among SUD, cannabis use (23.7%) was most prevalent in conduct disorder inpatients followed by tobacco and alcohol use (10.1% each). Conduct disorder inpatients have 1.7-fold higher odds (95% confidence interval (CI) 1.52–1.82) for alcohol use and 1.4-fold higher odds (95% CI 1.31–1.49) for cannabis use compared to the non-conduct disorder inpatients. Cannabis use was seen significantly in adolescents (49.1%, 12–15 years), male (75.6%), and African Americans (45.6%). Conclusion: Conduct disorder inpatients have a higher risk of comorbid SUD compared to other psychiatric illnesses. The most common substance to be abused is cannabis followed by tobacco and alcohol. Varying pattern of substance use was seen by demographics and these predictors may help the clinicians for early diagnosis and treatment to improve overall health-related quality of life.

APA, Harvard, Vancouver, ISO, and other styles

26

Limbu, S., DR Shakya, N. Sapkota, R. Gautam, and L. Paudel. "Tobacco Use, Dependence and Psychiatric Co-Morbidities Among Patients Admitted in Psychiatry Ward." Journal of Psychiatrists' Association of Nepal 6, no. 2 (November 22, 2018): 54–59. http://dx.doi.org/10.3126/jpan.v6i2.21763.

Full text

Abstract:

Introduction: Nicotine dependent individuals among the tobacco users are in greater risk of having tobacco related disease and psychiatric co-morbidities. There is little information about the tobacco use and nicotine dependence among psychiatric patients in developing countries including Nepal. This study was done to estimate the prevalence of tobacco use, the level of nicotine dependence among the users and the psychiatric disorder specific prevalence among tobacco users admitted in psychiatry ward.Material And Method: A cross-sectional study was conducted in In-patient setting of Department of Psychiatry, BPKIHS. Ninety cases (size) were enrolled. The Fagerström Test for Nicotine Dependence (FTND) was applied to assess the level of nicotine dependence and the Mini International Neuropsychiatric Interview (M.I.N.I.) for diagnosis of Psychiatric disorders.Results: The prevalence of tobacco use was 62.2%. Tobacco use was more common among males (p value< 0.05).Smokeless form was the commonest form of tobacco. Majority of tobacco users had moderate nicotine dependence and had started the use in adolescence and in their 20s. Psychotic disorders were the most common diagnosis among the admitted patients.Conclusion: Tobacco use is common in patients with psychiatric disorders. Nicotine dependence should be looked into for holistic management. Treatment approaches should be tailored in tobacco users with comorbid psychiatric disorders, as this specific population has high prevalence of tobacco use and higher nicotine dependence. J Psychiatrists’ Association of Nepal Vol. 6, No. 2, 2017, Page: 54-59

APA, Harvard, Vancouver, ISO, and other styles

27

Gau, Susan S. F., Mian-Yoon Chong, Pincheng Yang, Cheng-Fang Yen, Kung-Yee Liang, and Andrew T. A. Cheng. "Psychiatric and psychosocial predictors of substance use disorders among adolescents." British Journal of Psychiatry 190, no. 1 (January 2007): 42–48. http://dx.doi.org/10.1192/bjp.bp.106.022871.

Full text

Abstract:

BackgroundFew studies have prospectively examined psychosocial and psychiatric predictors of adolescent substance use disorders simultaneously.AimsTo identify psychosocial and psychiatric predictors of substance use disorders in adolescence.MethodSchool children aged 12 years (s. d. =0. 3) free from any substance use disorder at grade7(n=428) were assessed in three consecutive years, using a standardised psychiatric interview. Their baseline psychosocial information was also collected. The outcome was the onset age of a substance use disorder. The Cox regression model was used for data analysis.ResultsThe most significant predictive factors for adolescent substance use disorder included male gender, attention-deficit hyperactivity disorder, conduct disorder and sibling use of tobacco. Three protective factors against such morbidity included living in a household with two parents, a good academic grade at grade 7 and objection to the use of substances.ConclusionsEarly intervention for disruptive behaviour disorders and specific psychosocial risk factors might prevent substance use disorders in early adolescence.

APA, Harvard, Vancouver, ISO, and other styles

28

Wade, Darryl, Susy Harrigan, Jane Edwards, Philip M. Burgess, Greg Whelan, and Patrick D. Mcgorry. "Patterns and Predictors of Substance use Disorders and Daily Tobacco use in First-Episode Psychosis." Australian & New Zealand Journal of Psychiatry 39, no. 10 (October 2005): 892–98. http://dx.doi.org/10.1080/j.1440-1614.2005.01699.x.

Full text

Abstract:

Objective: To investigate the patterns and predictors of substance use disorders (SUD) and daily tobacco use in first-episode psychosis (FEP). Method: In this study, consecutive admissions of 126 patients with an initial presentation for FEP were recruited from three psychiatric services. Each patient was assessed with a comprehensive assessment package in order to collect demographic information, to diagnose psychotic disorders and SUD, to estimate the duration of untreated psychosis and to assess premorbid functioning and the severity of psychiatric symptoms. Results: The rates of lifetime SUD and daily tobacco use were 71% and 77%, respectively. The onset of SUD pre-dated the onset of positive psychotic symptoms in 91% of relevant cases. In multivariate analyses, male gender, younger age, Australian birth and unemployed status were the most consistent demographic predictors of SUD and daily tobacco use. There were no associations found between SUD and symptom severity, premorbid adjustment, psychotic disorder diagnosis or hospitalization. Conclusions: Male gender and younger age are reliable predictors of SUD in FEP. Patients with and without SUD appear to have similar clinical characteristics at initial presentation.

APA, Harvard, Vancouver, ISO, and other styles

29

Little, Melissa A., and Jon O. Ebbert. "The safety of treatments for tobacco use disorder." Expert Opinion on Drug Safety 15, no. 3 (December 30, 2015): 333–41. http://dx.doi.org/10.1517/14740338.2016.1131817.

Full text

APA, Harvard, Vancouver, ISO, and other styles

30

Valera Fernández, María Rosario, Ana María González Cuello, Rosa Aceña Domínguez, Ana Belén Valera Fernández, Antonio Rafael Moreno Poyato, and Francina Fonseca Casals. "Efectividad de una intervención de enfermería sobre abordaje al tabaquismo en personas con un trastorno mental." Nº 9 Diceimbre de 2019, no. 9 (December 12, 2019): 3–9. http://dx.doi.org/10.35761/reesme.2019.9.02.

Full text

Abstract:

Introduction: An important relationship has been found between tobacco use and various mental health-related disorders, with a higher prevalence of consumption, greater dependence on nicotine, lower attempts at abandonment and greater difficulty in achieving withdrawal, with respect to general population. Objective: To evaluate the effectiveness of a nursing intervention on smoking approach to generate motivation in the reduction of tobacco consumption or a complete smoking cessation to people with a serious mental disorder. Methodology: Pre-post quasi-experimental study, in which 25 users of partial, complete hospitalization and community care services participated.Aninitial interview and a group intervention is carried out. Results: The number of cigarettes is reduced by 9.4 cigarettes/day and the degree of self-efficacy is increased. The degree of nicotine dependence and the motivation to quit smoking are maintained. Improvement of blood pressure and blood pressure values. Conclusions:People with a mental disorder are motivated and interested in quitting their tobacco use. Keywords: tobacco, mental disorder, intervention, nursing, hospitalization.

APA, Harvard, Vancouver, ISO, and other styles

31

Sarfraz, Noeen, Yvon Fils-Aime, Michael Brand, Sara Vesely, and Laura Beebe. "Tobacco Use in Adults With Mental Illness: An Overview of One State-Wide Tobacco Cessation Program." Journal of Smoking Cessation 14, no. 2 (July 25, 2018): 132–37. http://dx.doi.org/10.1017/jsc.2018.27.

Full text

Abstract:

Even though one of the public health's top achievements of the 20th century involves tobacco cessation, a disproportionate burden of tobacco-related comorbidity still affects those with mental illness (Centers for Disease Control and Prevention, 2017; Cook et al., 2014). There is evidence suggesting that psychiatric disorders are associated with an increased prevalence in cigarette smoking (Tsoi, Porwa, & Webster, 2013). One explanation for this is the potentiating effect of nicotine on dopamine receptors (Mao, Gallagher, & McGehee, 2011). Other explanations include poverty, educational advancement and industry bias in tobacco marketing (MMWR Vital Signs: Current Cigarette, 2016; CDC Morbidity and Mortality, 2013). We know that adults with mental illness smoke at rates twice that of the general population, and are nicotine-dependent at rates up to three times higher than the general population (Cook et al., 2014; Grant, Hasin, Chou, Stinson, & Dawson, 2004). Adults with mental illness comprise about 19% of the population, but smoke approximately one-third of all the cigarettes smoked (MMWR Vital Signs: Current Cigarette, 2016). In the United States, the national tobacco use prevalence is estimated at 19%; however, prevalence among those with bipolar disorder is 51%–70% and 36%–80% among those with major depressive disorder (Grant et al., 2004; King, Dube, & Tynan, 2012; Lasser et al., 2000). Despite these high rates, recent studies suggest that smokers with mental illness are highly motivated to quit (Cook et al., 2014). However, it remains rare for mental and behavioural health professionals to offer tobacco cessation pharmacotherapy and counselling to clients with psychiatric disorders.

APA, Harvard, Vancouver, ISO, and other styles

32

Wilson, Nance, S. Leonard Syme, W. Thomas Boyce, Victor A. Battistich, and Steve Selvin. "Adolescent Alcohol, Tobacco, and Marijuana Use: The Influence of Neighborhood Disorder and Hope." American Journal of Health Promotion 20, no. 1 (September 2005): 11–19. http://dx.doi.org/10.4278/0890-1171-20.1.11.

Full text

Abstract:

Purpose. To investigate relationships between adolescents' current alcohol, tobacco, and marijuana use; perceptions of neighborhood disorder; and sense of hope. Design. Questionnaires were administered to a nonrandom sample of middle school students during the spring of 1999. Subjects. The ethnically and geographically diverse sample (n = 369), from a range of low socioeconomic status backgrounds, was considered to be at high risk for alcohol, tobacco, and other drug use because of previous enrollment in low socioeconomic status elementary schools. Measures. Alcohol, tobacco, and marijuana use were dichotomized into current and never/no use. Six variables described neighborhood social disorder. Sense of hope was assessed using the Children's Hope Scale. Results. Statistically significant relationships were found between perceived neighborhood disorder and current alcohol (p = .01), tobacco (p = .001), and marijuana (p < .001) use. A statistically significant and independent relationship was found between sense of hope and current alcohol (p = .02), tobacco (p = .02), and marijuana (p = .06) use. Results indicated linear trends in participants' increased use of alcohol, tobacco, and marijuana and (1) perception of higher neighborhood disorder and (2) lower sense of hope. Conclusion. Substance use prevention programs for youth might usefully be directed not only to agdolescents but also to the neighborhoods in which they live. Additionally, it would be important to emphasize creating safer neighborhood environments that support the development of a stronger sense of hope for the future.

APA, Harvard, Vancouver, ISO, and other styles

33

Kelly, Megan, Shihwe Wang, and Robert Rosenheck. "Use and correlates of VHA tobacco cessation counseling services by veterans with post-traumatic stress disorder." Journal of Public Mental Health 16, no. 1 (March 20, 2017): 37–44. http://dx.doi.org/10.1108/jpmh-08-2016-0035.

Full text

Abstract:

Purpose Veterans with post-traumatic stress disorder (PTSD) have high lifetime rates of smoking and often have substantial difficulty quitting. However, relatively little research has focussed on the use of Veterans Health Administration (VHA) intensive tobacco cessation counseling services by veterans with PTSD and the characteristics of veterans with PTSD who do and do not use these services. The paper aims to discuss these issues. Design/methodology/approach The present study is an analysis of national VHA administrative data fiscal year 2012 that identified utilization rates of VHA intensive tobacco cessation counseling among veterans with diagnoses of both PTSD and tobacco use disorder (TUD) (N=144,990) and the correlates of tobacco cessation counseling use. Findings Altogether, 7,921 veterans with PTSD diagnosed with TUD used VHA tobacco cessation services (5.5 percent). Veterans with PTSD who used tobacco cessation counseling services were more likely to have been homeless, to have a comorbid drug use disorder, and had used other VHA services more frequently than their counterparts who did not access tobacco cessation counseling. The use of outpatient mental health and substance use services was the strongest correlate of tobacco cessation counseling use by veterans in this sample. Notably, veterans with PTSD, TUD and HIV were more likely to engage in tobacco cessation services. Originality/value This study demonstrates that future efforts should focus on increasing provider and veteran awareness of and accessibility to VHA intensive tobacco cessation counseling for veterans with PTSD.

APA, Harvard, Vancouver, ISO, and other styles

34

Goodwin, R. D., M. J. Zvolensky, and K. M. Keyes. "Nicotine dependence and mental disorders among adults in the USA: evaluating the role of the mode of administration." Psychological Medicine 38, no. 9 (March 26, 2008): 1277–86. http://dx.doi.org/10.1017/s0033291708003012.

Full text

Abstract:

BackgroundTo investigate the association between nicotine dependence (ND), by cigarette smoking and use of smokeless tobacco (UST), and mental disorders.MethodFace-to-face surveys (n=43 093) were conducted in the 2001–2002 National Epidemiologic Survey on Alcohol and Related Conditions (NESARC). Nicotine use, ND, and mental disorders were assessed using DSM-IV criteria.ResultsUST-ND was associated with a significantly increased likelihood of any anxiety disorder, specific phobia, alcohol abuse and dependence. Consistent with previous findings, cigarette smoking-ND was associated with an increased likelihood of all mental disorders examined. Among those without ND, cigarette smoking was specifically associated with panic attacks and panic disorder; non-dependent UST was not associated with mental disorders.ConclusionsOur findings suggest that the association between ND and mental disorders is relatively specific to the mode of nicotine administration. Among those who are nicotine dependent, cigarette use is associated with most major psychiatric disorders, whereas UST is associated with dysthymia and specific phobia. Among those who use tobacco but are not nicotine dependent, cigarette use is associated with dysthymia and panic disorder; UST is not associated with any major mood or anxiety disorders. The link between mental disorders and nicotine is complex, and is associated primarily with dependence, and not with non-dependent use.

APA, Harvard, Vancouver, ISO, and other styles

35

Essenmacher, Carol, Carolyn Baird, Julia Houfek, M. Rene Spielmann, and Sara Adams. "Developing Competency-Based Nursing Treatment for Persons With Tobacco Use Disorder." Journal of the American Psychiatric Nurses Association 28, no. 1 (November 11, 2021): 23–36. http://dx.doi.org/10.1177/10783903211058785.

Full text

Abstract:

Background: Tobacco continues to have a deleterious impact on health outcomes in the United States. Professional nurses at all levels of practice have an opportunity to be a part of the solution. The development of nurse-specific competencies for treating tobacco use disorder (TUD) disorder is long overdue. A task force of American Psychiatric Nurses Association (APNA) subject matter experts was assembled to engage in the process of reviewing the available peer-reviewed literature and additional evidence-based resources (e.g., professional organization position statement, toolkits, national survey results) to create the Nursing Competencies for Treating Tobacco Use Disorders. Objective: The aim of this article is ultimately to improve patient access to quality, evidence-based TUD nursing care by all nurses who are competent, full partners in TUD multidisciplinary care. Method: Search terms were defined and a scoping search and review of the TUD literature and resources was performed from November 2018 to November 2020. Results: Over 300 articles and evidence-based resources (e.g., professional organization position statements, toolkits, etc.) were discovered. Thirteen competencies were developed and were internally and externally reviewed prior to APNA Board of Director’s approval. Conclusion: TUD competencies have the potential to guide nursing education, practice, and research, allowing nurses to be full partners in the design, development, and implementation of effective TUD treatment.

APA, Harvard, Vancouver, ISO, and other styles

36

Garcia-Portilla, M. P., P. A. Saiz, G. Florez, M. T. Bascaran, S. Al-Halabi, M. Bousoño, and J. Bobes. "Substance Use and Physical Health in Patients with Bipolar Disorder Under Maintenance Treatment." European Psychiatry 24, S1 (January 2009): 1. http://dx.doi.org/10.1016/s0924-9338(09)70810-7.

Full text

Abstract:

Background:To date, little is known about the impact of substance use on physical health of patients with bipolar disorder. This study provides data on the impact of tobacco, alcohol and cannabis upon weight, metabolic profile and cardiovascular risk in these patients.Methods:Naturalistic, cross-sectional, multicenter study conducted in Spain. Current use of tobacco, alcohol and cannabis was registered based on patient’ self-reports. Patients were evaluated for presence of metabolic syndrome (MetS) according to modified NCEP ATP III criteria, for cardiovascular risk using the Framinghan function (CHD) and the Systematic COronary Risk Evaluation (SCORE) function (CMR).Results:The mean age was 46.6 years and 49% were male. Fitty-one percent used tobacco, 13% alcohol and 12.5% cannabis. Mean body mass index (BMI) was 27.9 kg/m2, 22.4% had MetS and ten-year CHD and CMR risks were 7.6% and 1.8% respectively. Patients who used tobacco had significantly higher CHD risk (8.82 versus 5.74, p < 0.01), and used more antipsychotic (1.23 versus 1.04, p 0.002) and overall (3.18 versus 2.71, p 0.01) drugs for the treatment of their bipolar disorder. Patients who used cannabis had significantly lower BMI (26.0 versus 28.2, p < 0.05) and lower CMR (0.37 versus 1.99, p < 0.001), however, when controlling by age, severity of mania and presence of metabolic syndrome these associations disappear.Conclusions:Substance use, mainly tobacco, is high in patients with bipolar disorder. Use of tobacco is associated with higher cardiovascular risk and greater number of antipsychotic and overall drugs for the bipolar disorder.

APA, Harvard, Vancouver, ISO, and other styles

37

Okoli, Chizimuzo T. C., and Milan Khara. "Smoking Cessation Among Persons With Co-Occurring Substance Use Disorder and Mental Illness." Journal of Smoking Cessation 6, no. 1 (June 1, 2011): 58–64. http://dx.doi.org/10.1375/jsc.6.1.58.

Full text

Abstract:

AbstractAims:A history of either a substance use disorder (SUD) or psychiatric disorder (PD) is associated with tobacco use. However, there is limited information available on tobacco dependence treatment outcomes among individuals with co-occurring SUD and PD.Methods:Data from 202 participants enrolled in a tobacco dependence treatment program in an outpatient clinic setting were analysed.Findings:In multivariate analysis, having a history of SUD only (OR =.11, 95% CI = .02–.76) and having a co-occurring SUD and PD (OR = .13, 95% CI = .02–.81), as compared to having neither, were significant predictors of a lower likelihood of achieving smoking abstinence.Conclusions:A history of SUD and PD is an important predictor of poor smoking cessation outcomes; however, using more intensive, tailored approaches to tobacco dependence treatment appears to be promising. Future studies may need to further address the nature of tobacco dependence treatment in settings were PDs and other SUDs are managed in order to achieve optimal outcomes.

APA, Harvard, Vancouver, ISO, and other styles

38

Nik Mohamed, Mohamad Haniki. "Pharmacist’s role in the management of tobacco use disorder." International e-Journal of Science, Medicine & Education 13, no. 1 (2019): 1–3. http://dx.doi.org/10.56026/imu.13.1.1.

Full text

APA, Harvard, Vancouver, ISO, and other styles

39

Newton, Dwight F. "Peripheral Biomarkers Of Tobacco-Use Disorder: A Systematic Review." Addiction & Addictive Disorders 6, no. 2 (August 9, 2019): 1–11. http://dx.doi.org/10.24966/aad-7276/100026.

Full text

APA, Harvard, Vancouver, ISO, and other styles

40

Morphett, Kylie, and Coral Gartner. "Informed Choice in the Context of Tobacco Use Disorder." Nicotine & Tobacco Research 24, no. 1 (October 14, 2021): 1–2. http://dx.doi.org/10.1093/ntr/ntab215.

Full text

APA, Harvard, Vancouver, ISO, and other styles

41

Sutherland, Matthew T., and Elliot A. Stein. "Functional Neurocircuits and Neuroimaging Biomarkers of Tobacco Use Disorder." Trends in Molecular Medicine 24, no. 2 (February 2018): 129–43. http://dx.doi.org/10.1016/j.molmed.2017.12.002.

Full text

APA, Harvard, Vancouver, ISO, and other styles

42

Bohnert, Kipling M., Mark A. Ilgen, John F. McCarthy, Rosalinda V. Ignacio, Frederic C. Blow, and Ira R. Katz. "Tobacco use disorder and the risk of suicide mortality." Addiction 109, no. 1 (December 12, 2013): 155–62. http://dx.doi.org/10.1111/add.12381.

Full text

APA, Harvard, Vancouver, ISO, and other styles

43

Pehlivan, Sacide, Pınar Aydın, Hasan Aytaç, Mehmet Uysal, lgen Sever, and Mustafa Pehlivan. "Investigation of Catechol-O-Methyltransferase and Cannabinoid Receptor 2 gene variants in tobacco use disorder or tobacco use disorder and schizophrenia comorbidity." Anatolian Journal of Psychiatry 21 (2020): 1. http://dx.doi.org/10.5455/apd.91159.

Full text

APA, Harvard, Vancouver, ISO, and other styles

44

Warner, David O. "Anesthesiologists and the Other Pandemic: Tobacco Use." Anesthesiology 137, no. 4 (September 23, 2022): 484–508. http://dx.doi.org/10.1097/aln.0000000000004346.

Full text

Abstract:

Tobacco use will kill a projected 1 billion people in the 21st century in one of the deadliest pandemics in history. Tobacco use disorder is a disease with a natural history, pathophysiology, and effective treatment options. Anesthesiologists can play a unique role in fighting this pandemic, providing both immediate (reduction in perioperative risk) and long-term (reduction in tobacco-related diseases) benefits to their patients who are its victims. Receiving surgery is one of the most powerful stimuli to quit tobacco. Tobacco treatments that combine counseling and pharmacotherapy (e.g., nicotine replacement therapy) can further increase quit rates and reduce risk of morbidity such as pulmonary and wound-related complications. The perioperative setting provides a great opportunity to implement multimodal perianesthesia tobacco treatment, which combines multiple evidence-based tactics to implement the four core components of consistent ascertainment and documentation of tobacco use, advice to quit, access to pharmacotherapy, and referral to counseling resources.

APA, Harvard, Vancouver, ISO, and other styles

45

Budenz, Alexandra, Amanda Klein, and Yvonne Prutzman. "The Relationship Between Trauma Exposure and Adult Tobacco Use: Analysis of the National Epidemiologic Survey on Alcohol and Related Conditions (III)." Nicotine & Tobacco Research 23, no. 10 (April 13, 2021): 1716–26. http://dx.doi.org/10.1093/ntr/ntab057.

Full text

Abstract:

Abstract Introduction Previous research has examined cigarette smoking in trauma exposed populations. However, the relationships between trauma exposure and use of other tobacco products (eg, cigars, e-cigarettes) and specific trauma exposure characteristics that may be associated with tobacco use are understudied. Aims and Methods Using the 2012–2013 National Epidemiologic Survey on Alcohol and Related Conditions-III (N = 36 151 adults), we conducted weighted bivariate analyses of tobacco use among participants with no trauma exposure, trauma exposure, and trauma exposure with post-traumatic stress disorder (trauma + PTSD), stratified by tobacco product use. We also performed weighted logistic regressions testing relationships between trauma exposure and tobacco use, controlling for behavioral health (BH) conditions (mood, anxiety, substance use, personality disorders) and sociodemographics. Results Approximately 44% of participants had experienced trauma; 6% experienced trauma + PTSD. Trauma exposed participants had a higher prevalence of tobacco use (30%––46% vs. 22%) and poly-tobacco use (34%––35% vs. 28%) than unexposed participants. Cigarettes were the most used tobacco product; trauma + PTSD (19%), and trauma (15%) participants had a higher prevalence of e-cigarette use than unexposed participants (11%). Trauma exposure was associated with current tobacco use (AOR = 1.36 trauma + PTSD; 1.23 trauma) (but not former use), particularly among participants exposed to violence/abuse (AOR = 1.23). Personality and substance use disorders were strongly associated with current and former tobacco use. Conclusions Trauma exposure, PTSD, and experiences of violence/abuse are associated with current tobacco use. BH conditions may also play a role in current and former tobacco use. Recognizing and addressing trauma exposure and BH conditions among tobacco users may improve cessation rates in these populations. Implications This study contributes to research on tobacco use disparities in behavioral health populations by providing a comprehensive examination of tobacco use in trauma exposed individuals. Prior research has examined cigarette smoking, but not other tobacco product use in these populations. This study presents findings on multiple tobacco use behaviors (tobacco product, poly-tobacco use, cessation attempts) in trauma exposed populations and characteristics of trauma exposure (severity, type of traumatic event) associated with tobacco use. These findings underscore the importance of further examining the implications of trauma exposure for tobacco use and of screening and addressing trauma in cessation treatment.

APA, Harvard, Vancouver, ISO, and other styles

46

Swartz, James A., Dana Franceschini, and Kamryn Scamperle. "Mental health and substance use disorder comorbidities among Medicaid beneficiaries: Associations with opioid use disorder and prescription opioid misuse." AIMS Public Health 10, no. 3 (2023): 658–77. http://dx.doi.org/10.3934/publichealth.2023046.

Full text

Abstract:

<abstract><sec> <title>Background</title> Medicaid presently insures about one-fourth of the US population and disproportionately insures about 38 % of non-elderly adults with an opioid use disorder (OUD). Owing to Medicaid's prominent role insuring persons with an OUD and that Medicaid coverage includes pharmaceutical benefits, there has been considerable interest in studying potential prescription opioid misuse among Medicaid beneficiaries and identifying subpopulations at higher risk for misuse and possible progression to an OUD. </sec><sec> <title>Methods</title> The study goals were to explore the associations among prescription opioid misuse, OUD, and co-occurring mental health and other substance use disorders (SUD). We analyzed Illinois Medicaid 2018 claims data for 1102479 adult beneficiaries 18 to 64 years of age. Using algorithms based on previous studies, we first determined either the presence or absence of nine SUDS (including OUD), nine mental health disorders and likely prescription opioid misuse. Then, we subdivided the beneficiary sample into five groups: those who were prescribed opioids and evidenced either no, possible, or probable misuse; those evidencing an OUD; and those evidencing no opioid use or misuse. </sec><sec> <title>Results</title> Bivariate analyses, upset plots, and multinomial logistic regressions were used to compare the five subgroups on the prevalence of co-occurring SUDS and mental health disorders. Those with an OUD or with probable prescription opioid misuse had the highest prevalence of most co-occurring conditions with beneficiaries with an OUD the most likely to evidence co-occurring SUDS, particularly tobacco use disorder, whereas those with probable misuse had elevated prevalence rates of co-occurring mental health disorders comparable to those with an OUD. </sec><sec> <title>Conclusion</title> The medical complexity of persons with an OUD or misusing prescription opioids are considered in light of recent attempts to expand buprenorphine provision as a medication for OUD among Medicaid beneficiaries. Additionally, we consider the possibility of gender, co-occurring mental health disorders, and tobacco use disorder as important risk factors for progressing to prescription opioid misuse and an OUD. </sec></abstract>

APA, Harvard, Vancouver, ISO, and other styles

47

Siddiqi, Ammar D., Tzuan A. Chen, Maggie Britton, Isabel Martinez Leal, Brian J. Carter, Virmarie Correa-Fernández, Anastasia Rogova, et al. "Changes in Substance Use Treatment Providers’ Delivery of the 5A’s for Non-Cigarette Tobacco Use in the Context of a Comprehensive Tobacco-Free Workplace Program Implementation." International Journal of Environmental Research and Public Health 20, no. 3 (February 3, 2023): 2730. http://dx.doi.org/10.3390/ijerph20032730.

Full text

Abstract:

Tobacco use treatment is not prioritized in substance use treatment centers (SUTCs), leading to tobacco-related health inequities for patients with substance use disorders (SUDs) and necessitating efforts to enhance providers’ care provision. Training providers on how to treat tobacco use increases their intervention on patients’ smoking, but limited work addresses its effects on their non-cigarette tobacco use intervention provision. This study redressed this gap using data from 15 unaffiliated SUTCs in Texas (serving 82,927 patients/year) participating in a tobacco-free workplace program (TFWP) that included provider education on treating tobacco use, including non-cigarette tobacco use. SUTC providers completed surveys before (n = 259) and after (n = 194) TFWP implementation. Past-month screening/intervention provision for non-cigarette tobacco use (the 5A’s; ask, advise, assess, assist, arrange) and provider factors theoretically and practically presumed to underlie change [i.e., beliefs about concurrently treating tobacco use disorder (TUD) and other SUDs, self-efficacy for tobacco use assessment (TUA) delivery, barriers to treating tobacco dependence, receipt of tobacco intervention training] were assessed. Generalized linear or linear mixed models assessed changes over time from before to after TFWP implementation; low vs. high SUTC-level changes in provider factors were examined as moderators of changes in 5A’s delivery. Results indicated significant improvement in each provider factor and increases in providers’ asking, assisting, and arranging for non-cigarette tobacco use over time (ps < 0.04). Relative to their counterparts, SUTCs with high changes in providers’ beliefs in favor of treating patients’ tobacco use had greater odds of advising, assessing, assisting, and arranging patients, and SUTCs with greater barrier reductions had greater odds of advising and assisting patients. Results suggest that TFWPs can address training deficits and alter providers’ beliefs about treating non-tobacco TUD during SUD care, improve their TUA delivery self-efficacy, and reduce intervention barriers, ultimately increasing intervention provision for patients’ non-cigarette tobacco use. SUTCs with the greatest room for improvement in provider beliefs and barriers to care provision seem excellent candidates for TFWP implementation aimed at increasing non-cigarette tobacco use care delivery.

APA, Harvard, Vancouver, ISO, and other styles

48

Aubin, Henri-Jean, Amandine Luquiens, Stéphane Legleye, and Ivan Berlin. "Associations between substance use disorders and suicide mortality risk should be adjusted for tobacco use disorder." Addiction 112, no. 11 (August 14, 2017): 2066. http://dx.doi.org/10.1111/add.13919.

Full text

APA, Harvard, Vancouver, ISO, and other styles

49

Perka, Edward J. "Culture Change in Addictions Treatment." Health Promotion Practice 12, no. 6_suppl_2 (November 2011): 159S—165S. http://dx.doi.org/10.1177/1524839911414410.

Full text

Abstract:

Targeted training and technical assistance can have a major impact on the attitudes and beliefs of addiction service providers with respect to the treatment of tobacco dependency. Major gains have been made with the general public since the mid-1960s with respect to the reduction of tobacco use behavior and tobacco-related diseases. Tobacco use continues to be a major public health problem, and tobacco control initiatives are significantly affecting public attitudes and norms regarding tobacco use. There is, however, a specific population that has not benefited from these gains and, in fact, has been encouraged to continue smoking rather than make an attempt to quit. Individuals with a substance use disorder and/or mental health disorder have a much higher percentage of tobacco use than the general population, resulting in major health disparities. The addiction treatment and recovery community has lagged behind the general public in addressing tobacco use. New York State’s project, “Integrating Tobacco Use Interventions Into Chemical Dependence Services,” is a model that demonstrates how innovative regulations, and training and technical assistance developed specifically for addiction service providers, can initiate culture change with respect to tobacco use within addiction treatment settings, resulting in improved treatment outcomes and longer term stable recovery.

APA, Harvard, Vancouver, ISO, and other styles

50

Bates, Clive D. "POINT: e-Cigarette Use for Harm Reduction in Tobacco Use Disorder? Yes." Chest 160, no. 3 (September 2021): 807–9. http://dx.doi.org/10.1016/j.chest.2021.04.046.

Full text

APA, Harvard, Vancouver, ISO, and other styles

Journal articles on the topic 'Tobacco Use Disorder'

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles